当前位置：
X-MOL 学术
›
Ther. Adva. Endocrinol. Metab.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Update on genetics and epigenetics in metabolic associated fatty liver disease
Therapeutic Advances in Endocrinology and Metabolism ( IF 3.8 ) Pub Date : 2022-10-28 , DOI: 10.1177/20420188221132138 Xiaopeng Zhu 1 , Mingfeng Xia 2 , Xin Gao 1
Therapeutic Advances in Endocrinology and Metabolism ( IF 3.8 ) Pub Date : 2022-10-28 , DOI: 10.1177/20420188221132138 Xiaopeng Zhu 1 , Mingfeng Xia 2 , Xin Gao 1
Affiliation
Nonalcoholic fatty liver disease (NAFLD) is becoming the most frequent chronic liver disease worldwide. Metabolic (dysfunction) associated fatty liver disease (MAFLD) is suggested to replace the no...
中文翻译：
代谢相关脂肪肝的遗传学和表观遗传学更新
非酒精性脂肪性肝病 (NAFLD) 正在成为全球最常见的慢性肝病。建议代谢（功能障碍）相关的脂肪肝疾病（MAFLD）代替无...
更新日期：2022-10-28
中文翻译：
代谢相关脂肪肝的遗传学和表观遗传学更新
非酒精性脂肪性肝病 (NAFLD) 正在成为全球最常见的慢性肝病。建议代谢（功能障碍）相关的脂肪肝疾病（MAFLD）代替无...
京公网安备 11010802027423号